Literature DB >> 12491034

Children as a special population at risk--quinolones as an example for xenobiotics exhibiting skeletal toxicity.

Ralf Stahlmann1.   

Abstract

The sensitivity of the immature skeletal system during postnatal mammalian development was discussed during the workshop "Children as a Sensitive Subgroup and their Role in Regulatory Toxicology" (Schwenk et al. 2002, Arch Toxicol, in press). As a typical example of xenobiotics exhibiting this extraordinary type of toxicity, the quinolone-induced effects on cartilage, bone growth, and tendons were considered in depth. Animal experiments indicate that chondrotoxicity of quinolones can affect articular cartilage depending on the developmental stage. Results from studies with pipemidic acid in dogs at various developmental stages from 1 week old to 17 months old showed pronounced effects in the most sensitive age groups: 3- to 6-month-old dogs exhibited gait alterations and lameness, but signs of toxicity were not observed in 12- or 17-month-old dogs. Similarly, experiments performed in rats indicate that they exhibit the highest sensitivity for articular cartilage defects at a certain stage of development between 3 and 6 weeks postnatally; mature articular cartilage does not seem to be a target for quinolone-induced toxicity. Some very limited data indicate that in animals at an early developmental phase the epiphyseal growth plate can also be damaged by quinolones, and that these effects are associated with irreversible bone damage and growth inhibition. Another manifestation of toxic effects of quinolones on connective tissue structures are tendopathies. For this effect, it is not quite clear whether juveniles are more susceptible than adults because clinical and experimental data seem to point in different directions. Pathogenesis of both effects can probably be explained by the magnesium-chelating properties of these drugs, leading to a deficit of functionally available magnesium and, subsequently, to radical formation and irreversible connective tissue lesions. However, unequivocal explanations for the phase-dependency of the effects are lacking.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12491034     DOI: 10.1007/s00204-002-0412-0

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  5 in total

1.  Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats.

Authors:  Kerstin Pfister; Dago Mazur; Jürgen Vormann; Ralf Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

2.  "Effect of Subinhibitory Concentrations of Some Antibiotics and Low Doses of Gamma Radiation on the Cytotoxicity and Expression of Colibactin by an Uropathogenic Escherichia coli isolate".

Authors:  Radwa N Morgan; Hala A Farrag; Mohammad M Aboulwafa; Sarra E Saleh
Journal:  Curr Microbiol       Date:  2021-01-03       Impact factor: 2.188

3.  Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development.

Authors:  Wendy G Halpern; Mehrdad Ameri; Christopher J Bowman; Michael R Elwell; Michael L Mirsky; Julian Oliver; Karen S Regan; Amera K Remick; Vicki L Sutherland; Kary E Thompson; Claudine Tremblay; Midori Yoshida; Lindsay Tomlinson
Journal:  Toxicol Pathol       Date:  2016-05-27       Impact factor: 1.902

4.  The effect of fluoroquinolone antibiotics on growing cartilage in the lamb model.

Authors:  Jason M Sansone; Norman J Wilsman; Ellen M Leiferman; James Conway; Paul Hutson; Kenneth J Noonan
Journal:  J Pediatr Orthop       Date:  2009-03       Impact factor: 2.324

5.  Embryotoxic and teratogenic effects of norfloxacin in pregnant female albino rats.

Authors:  Mohamed Aboubakr; Mohamed Elbadawy; Ahmed Soliman; Mohamed El-Hewaity
Journal:  Adv Pharmacol Sci       Date:  2014-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.